iRhythm Technologies (NASDAQ: IRTC) reported Q2 EPS of ($0.61), $0.28 better than the analyst estimate of ($0.89). Revenue for the quarter came in at $148.04 million versus the consensus estimate of $146.16 million.

GUIDANCE

2024 Annual Guidance
iRhythm projects revenue for the full year 2024 to grow approximately 18% to 20% compared to prior year results, ranging from approximately $580 million to $590 million. Gross margin for the full year 2024 is expected to range from 68.5% to 69% and adjusted EBITDA margin for the full year 2024 is expected to range from approximately 3.5% to 4% of revenues.

For earnings history and earnings-related data on iRhythm Technologies (IRTC) click here.